Click for best price
Hepatitis Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 70680 million
|
Forecast Market size by 2029 |
US$ 297260 million
|
| Growth Rate |
CAGR of 22.8% |
Number of Pages |
75 Pages |
The global Hepatitis Drugs market was valued at US$ 70680 million in 2022 and is projected to reach US$ 297260 million by 2029, at a CAGR of 22.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Hepatitis is an inflammatory condition that occurs due to infection by hepatitis virus. It predominantly affects the liver and also causes damage to other body parts such as digestive system and brain. Apart from viral infections, hepatitis can also be caused by toxic substances, alcohol consumption, and autoimmune diseases. The viruses that cause hepatitis are of several types: A, B, C, D, E, and G. The most common type of hepatitis viruses are A, B, and C. Hepatitis viruses can cause either acute or chronic infections.
This report aims to provide a comprehensive presentation of the global market for Hepatitis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis Drugs. This report contains market size and forecasts of Hepatitis Drugs in global, including the following market information:
- Global Hepatitis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global Hepatitis Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
- Global top five Hepatitis Drugs companies in 2022 (%)
Factors such as growth in injection drug users, increase in awareness, presence of unmet need, and anticipated launch of new drugs are expected to drive the market growth during the forecast period. The market is witnessing the emerging trend of pediatric combination vaccines, which protect against multiple causative agents and thereby reduce the costs gain in packaging and administering individual vaccines. The markets in India, Brazil, China, and Russia are also expected to grow at a rapid pace during the forecast period as the prevalence of hepatitis in these countries is high.
We surveyed the Hepatitis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Drugs Market Segment Percentages, by Type, 2022 (%)
- VEMLIDY
- EPCLUSA
- SOVALDI
- INCIVEK
- OLYSIO
- VICTRELIS
- VIREAD
- HEPSERA
- BARACLUDE
- TYZEKA
Global Hepatitis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Drugs Market Segment Percentages, by Application, 2022 (%)
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis E
Global Hepatitis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Hepatitis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hepatitis Drugs revenues share in global market, 2022 (%)
Key companies Hepatitis Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Hepatitis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- F. Hoffmann-La Roche
- Gilead Sciences
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Vertex Pharmaceuticals
- Abbvie
- Achillion Pharmaceuticals
- Bristol-Myers Squibb
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Hepatitis Drugs, market overview.
- Chapter 2: Global Hepatitis Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of Hepatitis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Hepatitis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global Hepatitis Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hepatitis Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 70680 million
|
| Forecast Market size by 2029 |
US$ 297260 million
|
| Growth Rate |
CAGR of 22.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hepatitis Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hepatitis Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hepatitis Drugs Overall Market Size
2.1 Global Hepatitis Drugs Market Size: 2022 VS 2029
2.2 Global Hepatitis Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hepatitis Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Hepatitis Drugs Players in Global Market
3.2 Top Global Hepatitis Drugs Companies Ranked by Revenue
3.3 Global Hepatitis Drugs Revenue by Companies
3.4 Global Hepatitis Drugs Sales by Companies
3.5 Global Hepatitis Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hepatitis Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hepatitis Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis Drugs Players in Global Market
3.8.1 List of Global Tier 1 Hepatitis Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Hepatitis Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hepatitis Drugs Market Size Markets, 2022 & 2029
4.1.2 VEMLIDY
4.1.3 EPCLUSA
4.1.4 SOVALDI
4.1.5 INCIVEK
4.1.6 OLYSIO
4.1.7 VICTRELIS
4.1.8 VIREAD
4.1.9 HEPSERA
4.1.10 BARACLUDE
4.1.11 TYZEKA
4.2 By Type - Global Hepatitis Drugs Revenue & Forecasts
4.2.1 By Type - Global Hepatitis Drugs Revenue, 2018-2023
4.2.2 By Type - Global Hepatitis Drugs Revenue, 2024-2029
4.2.3 By Type - Global Hepatitis Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Hepatitis Drugs Sales & Forecasts
4.3.1 By Type - Global Hepatitis Drugs Sales, 2018-2023
4.3.2 By Type - Global Hepatitis Drugs Sales, 2024-2029
4.3.3 By Type - Global Hepatitis Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Hepatitis Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hepatitis Drugs Market Size, 2022 & 2029
5.1.2 Hepatitis A
5.1.3 Hepatitis B
5.1.4 Hepatitis C
5.1.5 Hepatitis D
5.1.6 Hepatitis E
5.2 By Application - Global Hepatitis Drugs Revenue & Forecasts
5.2.1 By Application - Global Hepatitis Drugs Revenue, 2018-2023
5.2.2 By Application - Global Hepatitis Drugs Revenue, 2024-2029
5.2.3 By Application - Global Hepatitis Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Hepatitis Drugs Sales & Forecasts
5.3.1 By Application - Global Hepatitis Drugs Sales, 2018-2023
5.3.2 By Application - Global Hepatitis Drugs Sales, 2024-2029
5.3.3 By Application - Global Hepatitis Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Hepatitis Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Hepatitis Drugs Market Size, 2022 & 2029
6.2 By Region - Global Hepatitis Drugs Revenue & Forecasts
6.2.1 By Region - Global Hepatitis Drugs Revenue, 2018-2023
6.2.2 By Region - Global Hepatitis Drugs Revenue, 2024-2029
6.2.3 By Region - Global Hepatitis Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Hepatitis Drugs Sales & Forecasts
6.3.1 By Region - Global Hepatitis Drugs Sales, 2018-2023
6.3.2 By Region - Global Hepatitis Drugs Sales, 2024-2029
6.3.3 By Region - Global Hepatitis Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Hepatitis Drugs Revenue, 2018-2029
6.4.2 By Country - North America Hepatitis Drugs Sales, 2018-2029
6.4.3 US Hepatitis Drugs Market Size, 2018-2029
6.4.4 Canada Hepatitis Drugs Market Size, 2018-2029
6.4.5 Mexico Hepatitis Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Hepatitis Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Hepatitis Drugs Sales, 2018-2029
6.5.3 Germany Hepatitis Drugs Market Size, 2018-2029
6.5.4 France Hepatitis Drugs Market Size, 2018-2029
6.5.5 U.K. Hepatitis Drugs Market Size, 2018-2029
6.5.6 Italy Hepatitis Drugs Market Size, 2018-2029
6.5.7 Russia Hepatitis Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Hepatitis Drugs Market Size, 2018-2029
6.5.9 Benelux Hepatitis Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Hepatitis Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Hepatitis Drugs Sales, 2018-2029
6.6.3 China Hepatitis Drugs Market Size, 2018-2029
6.6.4 Japan Hepatitis Drugs Market Size, 2018-2029
6.6.5 South Korea Hepatitis Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Hepatitis Drugs Market Size, 2018-2029
6.6.7 India Hepatitis Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Hepatitis Drugs Revenue, 2018-2029
6.7.2 By Country - South America Hepatitis Drugs Sales, 2018-2029
6.7.3 Brazil Hepatitis Drugs Market Size, 2018-2029
6.7.4 Argentina Hepatitis Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hepatitis Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Hepatitis Drugs Sales, 2018-2029
6.8.3 Turkey Hepatitis Drugs Market Size, 2018-2029
6.8.4 Israel Hepatitis Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Hepatitis Drugs Market Size, 2018-2029
6.8.6 UAE Hepatitis Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Hepatitis Drugs Major Product Offerings
7.1.4 F. Hoffmann-La Roche Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Hepatitis Drugs Major Product Offerings
7.2.4 Gilead Sciences Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Hepatitis Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Hepatitis Drugs Major Product Offerings
7.4.4 Johnson & Johnson Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Hepatitis Drugs Major Product Offerings
7.5.4 Merck Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Hepatitis Drugs Major Product Offerings
7.6.4 Novartis Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Vertex Pharmaceuticals
7.7.1 Vertex Pharmaceuticals Company Summary
7.7.2 Vertex Pharmaceuticals Business Overview
7.7.3 Vertex Pharmaceuticals Hepatitis Drugs Major Product Offerings
7.7.4 Vertex Pharmaceuticals Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Vertex Pharmaceuticals Key News & Latest Developments
7.8 Abbvie
7.8.1 Abbvie Company Summary
7.8.2 Abbvie Business Overview
7.8.3 Abbvie Hepatitis Drugs Major Product Offerings
7.8.4 Abbvie Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Abbvie Key News & Latest Developments
7.9 Achillion Pharmaceuticals
7.9.1 Achillion Pharmaceuticals Company Summary
7.9.2 Achillion Pharmaceuticals Business Overview
7.9.3 Achillion Pharmaceuticals Hepatitis Drugs Major Product Offerings
7.9.4 Achillion Pharmaceuticals Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Achillion Pharmaceuticals Key News & Latest Developments
7.10 Bristol-Myers Squibb
7.10.1 Bristol-Myers Squibb Company Summary
7.10.2 Bristol-Myers Squibb Business Overview
7.10.3 Bristol-Myers Squibb Hepatitis Drugs Major Product Offerings
7.10.4 Bristol-Myers Squibb Hepatitis Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Bristol-Myers Squibb Key News & Latest Developments
8 Global Hepatitis Drugs Production Capacity, Analysis
8.1 Global Hepatitis Drugs Production Capacity, 2018-2029
8.2 Hepatitis Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hepatitis Drugs Supply Chain Analysis
10.1 Hepatitis Drugs Industry Value Chain
10.2 Hepatitis Drugs Upstream Market
10.3 Hepatitis Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hepatitis Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hepatitis Drugs in Global Market
Table 2. Top Hepatitis Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hepatitis Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hepatitis Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Hepatitis Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Hepatitis Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hepatitis Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Hepatitis Drugs Product Type
Table 9. List of Global Tier 1 Hepatitis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hepatitis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hepatitis Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hepatitis Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hepatitis Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Hepatitis Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Hepatitis Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hepatitis Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hepatitis Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hepatitis Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Hepatitis Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Hepatitis Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hepatitis Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hepatitis Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hepatitis Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Hepatitis Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Hepatitis Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hepatitis Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hepatitis Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Hepatitis Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Hepatitis Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hepatitis Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hepatitis Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Hepatitis Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Hepatitis Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hepatitis Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hepatitis Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Hepatitis Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Hepatitis Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hepatitis Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hepatitis Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Hepatitis Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Hepatitis Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hepatitis Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hepatitis Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Hepatitis Drugs Sales, (K Units), 2024-2029
Table 46. F. Hoffmann-La Roche Company Summary
Table 47. F. Hoffmann-La Roche Hepatitis Drugs Product Offerings
Table 48. F. Hoffmann-La Roche Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. F. Hoffmann-La Roche Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Hepatitis Drugs Product Offerings
Table 52. Gilead Sciences Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Hepatitis Drugs Product Offerings
Table 56. GlaxoSmithKline Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Hepatitis Drugs Product Offerings
Table 60. Johnson & Johnson Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Hepatitis Drugs Product Offerings
Table 64. Merck Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Hepatitis Drugs Product Offerings
Table 68. Novartis Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Vertex Pharmaceuticals Company Summary
Table 71. Vertex Pharmaceuticals Hepatitis Drugs Product Offerings
Table 72. Vertex Pharmaceuticals Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Vertex Pharmaceuticals Key News & Latest Developments
Table 74. Abbvie Company Summary
Table 75. Abbvie Hepatitis Drugs Product Offerings
Table 76. Abbvie Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Abbvie Key News & Latest Developments
Table 78. Achillion Pharmaceuticals Company Summary
Table 79. Achillion Pharmaceuticals Hepatitis Drugs Product Offerings
Table 80. Achillion Pharmaceuticals Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Achillion Pharmaceuticals Key News & Latest Developments
Table 82. Bristol-Myers Squibb Company Summary
Table 83. Bristol-Myers Squibb Hepatitis Drugs Product Offerings
Table 84. Bristol-Myers Squibb Hepatitis Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Bristol-Myers Squibb Key News & Latest Developments
Table 86. Hepatitis Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 87. Global Hepatitis Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Hepatitis Drugs Production by Region, 2018-2023 (K Units)
Table 89. Global Hepatitis Drugs Production by Region, 2024-2029 (K Units)
Table 90. Hepatitis Drugs Market Opportunities & Trends in Global Market
Table 91. Hepatitis Drugs Market Drivers in Global Market
Table 92. Hepatitis Drugs Market Restraints in Global Market
Table 93. Hepatitis Drugs Raw Materials
Table 94. Hepatitis Drugs Raw Materials Suppliers in Global Market
Table 95. Typical Hepatitis Drugs Downstream
Table 96. Hepatitis Drugs Downstream Clients in Global Market
Table 97. Hepatitis Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hepatitis Drugs Segment by Type in 2022
Figure 2. Hepatitis Drugs Segment by Application in 2022
Figure 3. Global Hepatitis Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hepatitis Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hepatitis Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Hepatitis Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis Drugs Revenue in 2022
Figure 9. By Type - Global Hepatitis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hepatitis Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Hepatitis Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Hepatitis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hepatitis Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Hepatitis Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Hepatitis Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hepatitis Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hepatitis Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hepatitis Drugs Sales Market Share, 2018-2029
Figure 23. US Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hepatitis Drugs Sales Market Share, 2018-2029
Figure 28. Germany Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hepatitis Drugs Sales Market Share, 2018-2029
Figure 37. China Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hepatitis Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hepatitis Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hepatitis Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hepatitis Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hepatitis Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Hepatitis Drugs by Region, 2022 VS 2029
Figure 54. Hepatitis Drugs Industry Value Chain
Figure 55. Marketing Channels
